TEXIPY
LIVE

Serial Number

79426152

Owner

TAIHO PHARMACEUTICAL CO., LTD.

Attorney

Norm J. Rich

Filing Date

Apr 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TEXIPY Trademark

Serial Number: 79426152 • Registration: 8155806

TEXIPY is a trademark filed by TAIHO PHARMACEUTICAL CO., LTD. on April 24, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

TAIHO PHARMACEUTICAL CO., LTD. (107 trademarks)

CHIYODA-KU, TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

April 24, 2025

Registration Date

March 3, 2026

Published for Opposition

January 13, 2026

Goods & Services

Pharmaceutical preparations for the treatment, namely suppression, of tumors; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology, namely, for the treatment of cancers; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations and substances in the nature of immunomodulators; pharmaceutical preparations and substances in the nature of immunosuppressive agents; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations in the nature of anti-inflammatory preparations; chemical reagents for medical purposes in the field of oncology

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 3, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 3, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2025 CNSA
REFUSAL PROCESSED BY IB
Nov 30, 2025 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 9, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 9, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 23, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 22, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 27, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 27, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 24, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 19, 2025 REPR